| Product Name | Flibanserin-d4 |
| Product Code | DA-F042-b |
| Chemical name | Flibanserin-d4 |
| Synonyms | 1-(2-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)ethyl-1,1,2,2-d4)-1,3-dihydro-2H-benzo[d]imidazol-2-one; 1,3-Dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl-1,1,2,2-d4]-2H-benzimidazol-2-one; 2H-Benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl-1,1,2,2-d4]; |
| Impurity | NA |
| CAS Number | 2122830-91-3 |
| Alternate CAS # | NA |
| Molecular form | C20H17D4F3N4O |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 394.43 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | intermediates,pharmaceutical standards,amines,aromatics,Fine Chemicals,stable isotopes,agonists |
| Boiling Point | NA |
| Applications | Flibanserin-d4 is the labeled analogue of Flibanserin, a 5-HT1A agonist and 5-HT2A antagonist that is developed for the treatment of hypoactive sexual desire disorder in women. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
